HFS
ANIP icon

Hughes Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History

Hughes Financial Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331 Buy
4
+1
+33% +$80 ﹤0.01% 1173
2026
Q1 		$231 Buy
+3
New +$234 ﹤0.01% 1065

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's ANIP Position: Q2 2026 in Review

Hughes Financial Services increased its ANI Pharmaceuticals (ANIP) stake by 33% in Q2 2026, buying an estimated $80 and bringing the position to 4 shares worth $331. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

Hughes Financial Services first reported a position in ANIP in Q1 2026 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Hughes Financial Services held 4 shares of ANI Pharmaceuticals worth $331 as of Q2 2026.
  • Hughes Financial Services bought 1 ANI Pharmaceuticals share in Q2 2026, an estimated $80.
  • ANI Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1173 holding.
  • Hughes Financial Services first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.